ClinicalTrials.gg

Prometheus Biosciences, Inc. clinical trials

Acquired by Merck & Co., Inc, Jun 16, 2023 · source ↗

The registry lists 6 studies whose lead sponsor is Prometheus Biosciences, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 22, 2026.

Before and after it joined Merck & Co., Inc

First submitted before Prometheus Biosciences, Inc. became part of Merck & Co., Inc
6
First submitted after Prometheus Biosciences, Inc. became part of Merck & Co., Inc
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Prometheus Biosciences, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 6 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting117%
  • Completed583%

Phase

  • Phase 23
  • Phase 13

Where

  • United States6
  • Belgium3
  • Canada3
  • France3
  • Australia3
  • Poland3

Over the years

  1. 20
  2. 21
  3. 322
  4. 23
  5. 24
  6. 25
  7. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)6 studies

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 6 of 6. All Merck & Co., Inc studies →